The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 54 , ISSUE 1 ( January-March, 2012 ) > List of Articles

REVIEW ARTICLE

Exhaled Breath Condensate Analysis in Chronic Obstructive Pulmonary Disease

Sunil Kumar Chhabra, Mansi Gupta

Keywords : Chronic obstructive pulmonary disease, Exhaled breath condensate, Oxidative stress, 8-isoprostane, Hydrogen peroxide

Citation Information : Chhabra SK, Gupta M. Exhaled Breath Condensate Analysis in Chronic Obstructive Pulmonary Disease. Indian J Chest Dis Allied Sci 2012; 54 (1):27-37.

DOI: 10.5005/ijcdas-54-1-27

License: CC BY-NC 4.0

Published Online: 16-06-2022

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract

The increasing focus on airway inflammation in the pathogenesis of chronic obstructive pulmonary disease (COPD) has led to development and evolution of tools to measure it. Direct assessment of airway inflammation requires invasive procedures, and hence, has obvious limitations. Non-invasive methods to sample airway secretions and fluids offer exciting prospects. Analysis of exhaled breath condensate (EBC) is rapidly emerging as a novel non-invasive approach for sampling airway epithelial lining fluid and offers a convenient tool to provide biomarkers of inflammation. It has definite advantages that make it an attractive and a feasible option. It is a source of mediators and molecules that are the causes or consequences of the inflammatory process. Measurement of such markers is increasingly being explored for studying airway inflammation qualitatively and quantitatively in research studies and for potential clinical applications. These biomarkers also have the potential to develop into powerful research tools in COPD for identifying various pathways of pathogenesis of COPD that may ultimately provide specific targets for therapeutic intervention. The EBC analysis is still an evolving noninvasive method for monitoring of inflammation and oxidative stress in the airways. The limited number of studies available on EBC analysis in COPD have provided useful information although definite clinical uses are yet to be defined. Evolving technologies of genomics, proteomics, and metabonomics may provide deeper and newer insights into the molecular mechanisms underlying the pathogenesis of COPD


PDF Share
  1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD).Executive summary update 2010. www.goldcopd.org.
  2. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005;29:23-32.
  3. Lee W, Thomas PS. Oxidative stress in COPD and its measurement through exhaled breath condensate. Clin Transl Sci 2009;2:150-5.
  4. Lin JL, Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD 2010;7:291-306.
  5. He Z, Chen Y, Chen P, Wu G, Cai S. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology 2010;15:478-84.
  6. van Beurden WJC, Harff GA, Dekhuijzen PNR, van den Bosch MJ, Creemers JP, Smeenk FW. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002;96:197-203.
  7. Gerritsen WB, Asin J, Zanen P, van den Bosch JM, Haas FJ. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 2005;99:84-90.
  8. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, et al Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-7.
  9. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003;124:1373-80.
  10. Izquierdo JL, Almonacid C, Parra T, Pérez J. Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease. Arch Bronconeumol 2006;42:332-7.
  11. Inonu H, Doruk S, Sahin S, Erkorkmaz U, Celik D, Celikel S, et al. The comparison of oxidative stress levels in exhaled breath condensate between patients with chronic obstructive pulmonary disease and smokers. Respir Care 2011 Sep 26. [Epub ahead of print]
  12. Mazur W, Stark H, Sovijärvi A, Myllärniemi M, Kinnula VL. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers. Respiration 2009;78:209-16.
  13. Antczak A, Piotrowski W, Marczak J, Ciebiada M, Gorski P, Barnes PJ. Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate. Dis Markers 2011;30:213-20.
  14. Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, et al. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2008;75:138-44.
  15. García-Rio F, Romero D, Lores V, Casitas R, Hernanz A, Galera R, et al. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD. Chest 2011;140:961-9.
  16. Guatura SB, Martinez JA, Santos Bueno PC, Santos ML. Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Sao Paulo Med J 2000;118:93-8.
  17. Dekhuijzen PNR, Aben KKH, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:813-6.
  18. Nowak D, Kasielski M, Pietras T, Bialasiewicz P, Antczak A. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis 1998;53:268-73.
  19. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acidreactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999;93:389-96.
  20. Möller W, Heimbeck I, Weber N, Khadem Saba G, Körner B, Neiswirth M, et al. Fractionated exhaled breath condensate collection shows high hydrogen peroxide release in the airways. J Aerosol Med Pulm Drug Deliv 2010;23:129-35.
  21. Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med 2001;164:1012-5.
  22. Kasielski M, Nowak D. Long-term administration of Nacetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001;95:448-56.
  23. van Beurden WJ, Smeenk FW, Harff GA, Dekhuijzen PN. Markers of inflammation and oxidative stress during lower respiratory tract infections in COPD patients. Monaldi Arch Chest Dis 2003;59:273-80.
  24. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-8.
  25. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005;127:1553-9.
  26. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002;109:615-20.
  27. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003;58:585-8.
  28. Ko FW, Leung TF, Wong GW, Ngai J, To KW, Ng S, et al. Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin-8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4:79-86.
  29. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha ZA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
  30. Ko FW, Lau CY, Leung TF, Wong GW, Lam CW, Hui DS. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir Med 2006;100:630-8.
  31. Ricciardolo FL, Gaston B, Hunt J. Acid stress in the pathology of asthma. J Allergy Clin Immunol 2004;113: 610-9.
  32. Koczulla R, Dragonieri S, Schot R, Bals R, Gauw SA, Vogelmeier C, et al. Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res 2009;10:78.
  33. Borrill Z, Starkey C, Vestbo J, Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 2005;25:269-74.
  34. Papaioannou A, Loukides S, Minas M, Zhang J, Wang C. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers. Respir Res 2011;12:67-73.
  35. MacNee W, Rennard SI, Hunt JF, Edwards LD, Miller BE, Locantore NW, et al. Evaluation of exhaled breath condensate pH as a biomarker for COPD. Respir Med 2011;105:1037-45.
  36. Bartoli ML, Novelli F, Costa F, Malagrinò L, Melosini L, Bacci E, et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm 2011;2011:891752
  37. Esther CR Jr, Lazaar AL, Bordonali E, Qaqish B, Boucher RC. Elevated airway purines in COPD. Chest 2011;140: 954-60.
  38. Kharitonov SA, Chung FK, Evans DJ, O'Connor BJ, Barnes PJ. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996;153:1773-80.
  39. Brindicci C, Cosio B, Gajdocsi R, Collins JV, Bush A, Abdallah S, et al. Extended exhaled NO measurements at different exhalation flows may differentiate between bronchial and alveolar inflammation in patients with asthma and COPD. Eur Respir J 2002;20:174s.
  40. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001;163:854-8.
  41. Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration 2007; 74:617-23.
  42. Kharitonov SA, Barnes PJ. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:191-9.
  43. Borrill ZL, Roy K D. Singh D. Exhaled breath condensate biomarkers in COPD. Eur Respir J 2008;32:472-86.
  44. Horvath I, Hunt J, Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-48.
  45. Rosias PP, Robroeks CM, Niemarkt HJ, Kester AD, Vernooy JH, Suykerbuyk J, et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 2006;28:1036-41.
  46. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H, Jorres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000;16:1115-8.
  47. McCafferty JB, Bradshaw TA, Tate S, Greening AP, Innes JA. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 2004;59:694-8.
  48. Gaber F, Acevedo F, Delin I, Sundblad BM, Palmberg L, Larsson K, et al. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 2006; 28:1229-35.
  49. Vass G, Huszár E, Barát E, Valyon M, Kiss D, Penzes I, et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 2003;167:850-5.
  50. Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003;22:889-94.
  51. Wells K, Vaughan J, Pajewski TN, Hom S, Ngamtrakulpanit L, Smith A, et al. Exhaled breath condensate pH assays are not influenced by oral ammonia. Thorax 2005;60:27-31.
  52. Marteus H, Tornberg DC, Weitzberg E, Schedin U, Alving K. Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax 2005;60:219-25.
  53. Gaber F, Acevedo F, Delin I, Sundblad BM, Palmberg L, Larsson K, et al. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 2006; 28:1229-35.
  54. Nowak D, Kalucka S, Bialasiewicz P, Krol M. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30:178-86.
  55. van Beurden WJ, Dekhuijzen PN, Harff GA, Smeenk FW. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002;69:211-6.
  56. Koutsokera A, Loukides S, Gourgoulianis KI, Kostikas K. Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem 2008;15:620-30.
  57. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, Schouten EG, Dupont LJ, Temme EH. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004;23:189-92.
  58. Borrill ZL, Starkey RC, Singh SD. Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:71-6.
  59. Vogelberg C, Hirsch T, Rösen-Wolff A, Kerkmann ML, Leupold W. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Pediatr Pulmonol 2003;36:348-52.
  60. Casado B, Luisetti M, Iadarola P. Advances in proteomic techniques for biomarker discovery in COPD. Expert Rev Clin Immunol 2011;7:111-23.
  61. Casado B, Iadarola P, Luisetti M, Kussmann M. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev Proteomics 2008;5:693-704.
  62. de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 2008;32:1175-83.
  63. Sofia M, Maniscalco M, de Laurentiis G, Paris D, Melck D, Motta A. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J Biomed Biotechnol 2011;2011:403260. Epub 2011 Mar 15.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.